Bob has an extensive background of leadership, innovation, and entrepreneurship in the medical device industry. Bob is a founder of Inceptus Medical, a medical device incubator founded in 2011, and serves as President and CEO. Inceptus Medical incubated both Inari Medical (NASDAQ: NARI) where Bob was a founder, CEO and Chairman of the Board, and Okami Medical where he currently serves as CEO and Chairman of the Board. Prior to Inceptus, Inari and Okami, Bob was a founder and CEO of Sequent Medical. Sequent was acquired by Terumo Medical Corporation for $380M. Before Sequent, Bob was a founder of MicroVention, serving as President and CEO since its inception in 1997 through 2002 and as Chairman of the Board from inception through its acquisition by Terumo. Prior to founding MicroVention, he founded Advanced Surgical Intervention and served in various R&D, business development and senior management positions at Medtronic, Pfizer, and Cardiothoracic Systems. He holds a B.S. in Chemical Engineering from Columbia University, and an M.S. in Chemical Engineering and Ph.D. in Mechanical Engineering from University of California, Berkeley.
Paul Lubock
Paul is a Principal and a founder of Inceptus Medical, a medical device incubator founded in 2011. At Inceptus he was a founder of Inari Medical (NASDAQ: NARI) and served as Vice President until 2017 and on the Board of Directors from 2011 until 2020. At Inceptus, he is also a founder of Okami Medical and serves as Vice President and on the Board of Directors. He also served as Okami’s Vice President of R&D and Operations. Prior to Inceptus, he was a founder of SenoRx, which was acquired by C.R. Bard for $213M. He served as Chief Technical Officer from 1999 and Senior Vice President from April 2009 until his departure in 2011. Paul also served on the Board of Directors from 1998 to 2001 and served as Chief Operating Officer from 1998 to 1999. Prior to 1998, Paul was a founder and President of Abacus Design & Development, a medical product development company, and the founder of Laparomed, which was acquired by Advanced Surgical. Paul held various positions at Laparomed, including President, Vice President of Engineering and served on its Board of Directors. Previously he was Vice President of Engineering at Medstone and held engineering management roles at Shiley/Pfizer and Thoratec. Paul holds over 185 issued U.S. patents. He earned his B.A. in Applied Mechanics and Engineering Science from the University of California, San Diego and his M.S. in Mechanical Engineering from the University of California, Berkeley.
Brian Cox
Brian is a founder of Inceptus Medical, a medical device incubator founded in 2011. At Inceptus, he was a founder of Inari Medical (NASDAQ: NARI) and Okami Medical. Prior to Inceptus, Brian was a founder of Sequent Medical where he served as Vice President and Chief Technical Officer. Sequent was acquired by Terumo Medical Corporation for $380M. Prior to Sequent, Brian was a founder of MicroVention which was acquired by Terumo. At MicroVention, Brian served as Vice President of Business and Technology Development. Prior to MicroVention, Brian was Engineering Manager at AneuRx, which was acquired by Medtronic. Prior to AneuRx, he held various managerial and technical positions with Advanced Surgical Intervention, Allergan Medical Optics, and Shiley/Pfizer. He earned a B.S. in Mechanical Engineering from Oregon State University and a M.B.A. from Pepperdine University. Brian is an inventor on over 100 issued U.S. and international patents.
Terry Hardin
Terry has broad functional experience in the medical device space with a focus on early stage companies. Terry is a Vice President of Inceptus Medical, a medical device incubator, and Vice President of Okami Medical, which was incubated by Inceptus Medical. Prior to Inceptus and Okami, he served as Vice President of Technology and Product Management for Cianna Medical, which developed and introduced the SCOUT Radar Surgical Guidance System. The company was acquired by Merit Medical for $135M. Prior to Cianna, Terry was a Product Development Engineer at Suros Surgical Systems, helping to develop an innovative product line that led to a $240M acquisition by Hologic. Terry earned his B.S. in Chemical Engineering and M.S. in Biomedical Engineering from Rose-Hulman Institute of Technology. He is an inventor on over 15 issued U.S. and international patents.